Chem. J. Chinese Universities ›› 2011, Vol. 32 ›› Issue (6): 1231.

• Letters • Previous Articles     Next Articles

Electrochemical Behavior of  Isocyanate as Novel Film-forming Additive in Electrolytes

XIANG Jin, CHEN Ren-Jie*, WU Feng, LI Li, CHEN Shi   

  1. School of Chemical Engineering and the Environment, Beijing Key Laboratory of Environmental Science and Engineering, Beijing Institute of Technology, Beijing 100081, China
  • Received:2010-12-15 Revised:2011-04-12 Online:2011-06-10 Published:2011-05-10
  • Contact: CHEN Ren-Jie E-mail:chenrj@bit.edu.cn
  • Supported by:

    国家“九七三”计划项目(批准号:   2009CB220100)、 国家自然科学基金(批准号: 20803003)、 国家国际科技合作计划(批准号: 2010DFB63370)、 教育部新世纪优秀人才支持计划(批准号: NCET-10-00382006)和北京市优秀人才培养资助项目(批准号: 2010D009011000005)资助.

Abstract: New sulfone-isocyanate mixed electrolytes based on tetramethylene sulfone (TMS) and p-toluenesulfonyl isocyanate (PTSI) were prepared, and their physiochemical properties and their electrochemical behaviors on the mesocarbon microbeads electrode (MCMB) were investigated by galvanostatic charge-discharge and cyclic voltammetry (CV). The results show that the electrochemical window of the electrolytes are over 5.0 V. Moreover, the mixed electrolytes even perform good thermal stability. Compared with pure TMS-based electrolytes, the mixed electrolytes show better wettability and improved lithiation/delithiation reversibility. The Li/MCMB half-cell exhibits a specific capacity of over 360 mAh/g with excellent capacity retention after 50 cycles when combined with a composite electrolyte containing 5 vol% PTSI because an effective solid electrolyte interface layer is thought to form. The energies of the lowest unoccupied and highest occupied molecular orbitals of PTSI are lower than those of TMS and vinylene carbonate, indicating that PTSI molecules can accept electrons readily and possess a high oxidation potential.

Key words: p-toluenesulfonyl isocyanate, tetramethylene sulfone, mesocarbon microbeads electrode, electrochemical window, reversibility

CLC Number: 

TrendMD: